EBS logo

Emergent BioSolutions (EBS) Interest Expense

Annual Interest Expense

$87.90 M
+$50.60 M+135.66%

December 31, 2023

Summary

Performance

1-Year Change

+135.66%

3-Year Change

+180.83%

5-Year Change

+787.88%

15-Year Change

+1231.82%

EBS Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.24%
EBS annual interest expense is higher than 88.24% of companies in Healthcare sector

High & Low

All-time High

$87.90 M
EBS annual interest expense is currently at an all-time high

3-Year Low

$34.50 M
EBS annual interest expense is currently +154.78% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EBS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 3, 2025
EBS next annual earnings announcement is scheduled for Mar 3, 2025

OtherEBSexpensesmetrics:

Annual Total Expenses

$1.22 B
EBS annual total expenses is $1.22 billion

Annual Operating Expenses

$519.10 M
EBS annual total operating expenses is $519.10 million

Annual Cost Of Goods Sold

$705.40 M
EBS annual cost of goods sold is $705.40 million

Annual Income Tax

$29.30 M
EBS annual income tax is $29.30 million

Quarterly Interest Expense

$8.30 M
-$15.30 M-64.83%

September 30, 2024

Summary

Performance

3-Month Change

-64.83%

1-Year Change

-64.83%

3-Year Change

-7.78%

5-Year Change

-2.35%

EBS Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.09%
EBS quarterly interest expense is higher than 78.09% of companies in Healthcare sector

High & Low

All-time High

$28.60 M
EBS quarterly interest expense is currently -70.98% below its historical high of $28.60 million

3-Year Low

$7.80 M
EBS quarterly interest expense is currently +6.41% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EBS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 3, 2025
EBS next earnings announcement is scheduled for Mar 3, 2025

OtherEBSexpensesmetrics:

Quarterly Total Expenses

$219.30 M
EBS quarterly total expenses is $219.30 million

Quarterly Operating Expenses

$96.70 M
EBS quarterly total operating expenses is $96.70 million

Quarterly Cost Of Goods Sold

$122.60 M
EBS quarterly cost of goods sold is $122.60 million

Quarterly Income Tax

$27.60 M
EBS quarterly income tax is $27.60 million

TTM Interest Expense

$77.90 M
-$11.40 M-12.77%

September 30, 2024

Summary

Performance

3-Month Change

-12.77%

1-Year Change

-12.77%

3-Year Change

+125.8%

5-Year Change

+149.68%

EBS TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.63%
EBS TTM interest expense is higher than 86.63% of companies in Healthcare sector

High & Low

All-time High

$94.30 M
EBS TTM interest expense is currently -17.39% below its historical high of $94.30 million

3-Year Low

$33.40 M
EBS TTM interest expense is currently +133.23% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EBS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 3, 2025
EBS next earnings announcement is scheduled for Mar 3, 2025

OtherEBSexpensesmetrics:

Annual Total Expenses

$1.22 B
EBS annual total expenses is $1.22 billion

Annual Operating Expenses

$519.10 M
EBS annual total operating expenses is $519.10 million

TTM Cost Of Goods Sold

$748.40 M
EBS TTM cost of goods sold is $748.40 million

TTM Income Tax

$39.00 M
EBS TTM income tax is $39.00 million

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

EBS Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+135.7%-64.8%-12.8%
3 y3 years+180.8%-7.8%+125.8%
5 y5 years+787.9%-2.4%+149.7%

EBS Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+154.8%-71.0%+6.4%-17.4%+133.2%
5 y5-yearat high+180.8%-71.0%+29.7%-17.4%+149.7%
alltimeall timeat high-100.0%-71.0%>+9999.0%-17.4%-100.0%

Emergent BioSolutions Interest Expense History

DateAnnualQuarterlyTTM
Sep 2024
-
$8.30 M(-64.8%)
$77.90 M(-12.8%)
Jun 2024
-
$23.60 M(-2.9%)
$89.30 M(-5.3%)
Mar 2024
-
$24.30 M(+12.0%)
$94.30 M(+7.3%)
Dec 2023
$87.90 M(+135.7%)
$21.70 M(+10.2%)
$87.90 M(+11.3%)
Sep 2023
-
$19.70 M(-31.1%)
$79.00 M(+16.5%)
Jun 2023
-
$28.60 M(+59.8%)
$67.80 M(+44.3%)
Mar 2023
-
$17.90 M(+39.8%)
$47.00 M(+26.0%)
Dec 2022
$37.30 M(+8.1%)
$12.80 M(+50.6%)
$37.30 M(+11.3%)
Sep 2022
-
$8.50 M(+9.0%)
$33.50 M(+0.3%)
Jun 2022
-
$7.80 M(-4.9%)
$33.40 M(-2.3%)
Mar 2022
-
$8.20 M(-8.9%)
$34.20 M(-0.9%)
Dec 2021
$34.50 M(+10.2%)
$9.00 M(+7.1%)
$34.50 M(+0.9%)
Sep 2021
-
$8.40 M(-2.3%)
$34.20 M(+2.4%)
Jun 2021
-
$8.60 M(+1.2%)
$33.40 M(+7.1%)
Mar 2021
-
$8.50 M(-2.3%)
$31.20 M(-0.3%)
Dec 2020
$31.30 M(-18.5%)
$8.70 M(+14.5%)
$31.30 M(-1.3%)
Sep 2020
-
$7.60 M(+18.8%)
$31.70 M(-7.8%)
Jun 2020
-
$6.40 M(-25.6%)
$34.40 M(-8.3%)
Mar 2020
-
$8.60 M(-5.5%)
$37.50 M(-2.6%)
Dec 2019
$38.40 M(+287.9%)
$9.10 M(-11.7%)
$38.50 M(+2.7%)
Sep 2019
-
$10.30 M(+8.4%)
$37.50 M(+34.9%)
Jun 2019
-
$9.50 M(-1.0%)
$27.80 M(+44.0%)
Mar 2019
-
$9.60 M(+18.5%)
$19.30 M(+94.9%)
Dec 2018
$9.90 M(+50.0%)
$8.10 M(+1250.0%)
$9.90 M(+271.3%)
Sep 2018
-
$600.00 K(-40.0%)
$2.67 M(-34.3%)
Jun 2018
-
$1.00 M(+400.0%)
$4.06 M(-16.6%)
Mar 2018
-
$200.00 K(-76.9%)
$4.86 M(-26.3%)
Dec 2017
$6.60 M(-13.2%)
$866.00 K(-56.5%)
$6.60 M(-20.0%)
Sep 2017
-
$1.99 M(+10.3%)
$8.25 M(-0.7%)
Jun 2017
-
$1.80 M(-6.9%)
$8.31 M(+3.7%)
Mar 2017
-
$1.94 M(-23.0%)
$8.02 M(+5.4%)
Dec 2016
$7.60 M
$2.52 M(+22.9%)
$7.60 M(+13.7%)
DateAnnualQuarterlyTTM
Sep 2016
-
$2.05 M(+35.7%)
$6.68 M(+6.6%)
Jun 2016
-
$1.51 M(-0.9%)
$6.27 M(-1.8%)
Mar 2016
-
$1.52 M(-4.8%)
$6.39 M(-2.1%)
Dec 2015
$6.52 M(-20.8%)
$1.60 M(-2.1%)
$6.52 M(+7.0%)
Sep 2015
-
$1.64 M(+0.4%)
$6.10 M(-2.8%)
Jun 2015
-
$1.63 M(-2.0%)
$6.27 M(-1.5%)
Mar 2015
-
$1.66 M(+41.5%)
$6.37 M(-22.7%)
Dec 2014
$8.24 M(>+9900.0%)
$1.17 M(-35.1%)
$8.24 M(+16.6%)
Sep 2014
-
$1.81 M(+5.2%)
$7.07 M(+34.4%)
Jun 2014
-
$1.72 M(-51.3%)
$5.26 M(+48.6%)
Mar 2014
-
$3.54 M(>+9900.0%)
$3.54 M(>+9900.0%)
Sep 2013
-
$0.00(-100.0%)
$20.00 K(0.0%)
Jun 2013
-
$3000.00(-72.7%)
$20.00 K(+17.6%)
Mar 2013
-
$11.00 K(+83.3%)
$17.00 K(+88.9%)
Dec 2012
$6000.00(>+9900.0%)
$6000.00(>+9900.0%)
$9000.00(+200.0%)
Sep 2012
-
$0.00(0.0%)
$3000.00(0.0%)
Jun 2012
-
$0.00(-100.0%)
$3000.00(-66.7%)
Mar 2012
-
$3000.00(>+9900.0%)
$9000.00(+50.0%)
Dec 2011
$0.00(0.0%)
$0.00(0.0%)
$6000.00(0.0%)
Sep 2011
-
$0.00(-100.0%)
$6000.00(0.0%)
Jun 2011
-
$6000.00(>+9900.0%)
$6000.00(+200.0%)
Mar 2011
-
$0.00(0.0%)
$2000.00(-71.4%)
Dec 2010
$0.00(-100.0%)
$0.00(0.0%)
$7000.00(>+9900.0%)
Sep 2010
-
$0.00(-100.0%)
$0.00(-100.0%)
Jun 2010
-
$2000.00(-60.0%)
$4000.00(-50.0%)
Mar 2010
-
$5000.00(-171.4%)
$8000.00(+14.3%)
Dec 2009
$7000.00(-85.1%)
-$7000.00(-275.0%)
$7000.00(-50.0%)
Sep 2009
-
$4000.00(-33.3%)
$14.00 K(+40.0%)
Jun 2009
-
$6000.00(+50.0%)
$10.00 K(+11.1%)
Mar 2009
-
$4000.00(-20.0%)
$9000.00(+50.0%)
Dec 2008
$47.00 K
-
-
Jun 2008
-
$5000.00(+400.0%)
$6000.00(+500.0%)
Mar 2008
-
$1000.00
$1000.00

FAQ

  • What is Emergent BioSolutions annual interest expense?
  • What is the all time high annual interest expense for Emergent BioSolutions?
  • What is Emergent BioSolutions annual interest expense year-on-year change?
  • What is Emergent BioSolutions quarterly interest expense?
  • What is the all time high quarterly interest expense for Emergent BioSolutions?
  • What is Emergent BioSolutions quarterly interest expense year-on-year change?
  • What is Emergent BioSolutions TTM interest expense?
  • What is the all time high TTM interest expense for Emergent BioSolutions?
  • What is Emergent BioSolutions TTM interest expense year-on-year change?

What is Emergent BioSolutions annual interest expense?

The current annual interest expense of EBS is $87.90 M

What is the all time high annual interest expense for Emergent BioSolutions?

Emergent BioSolutions all-time high annual interest expense is $87.90 M

What is Emergent BioSolutions annual interest expense year-on-year change?

Over the past year, EBS annual interest expense has changed by +$50.60 M (+135.66%)

What is Emergent BioSolutions quarterly interest expense?

The current quarterly interest expense of EBS is $8.30 M

What is the all time high quarterly interest expense for Emergent BioSolutions?

Emergent BioSolutions all-time high quarterly interest expense is $28.60 M

What is Emergent BioSolutions quarterly interest expense year-on-year change?

Over the past year, EBS quarterly interest expense has changed by -$15.30 M (-64.83%)

What is Emergent BioSolutions TTM interest expense?

The current TTM interest expense of EBS is $77.90 M

What is the all time high TTM interest expense for Emergent BioSolutions?

Emergent BioSolutions all-time high TTM interest expense is $94.30 M

What is Emergent BioSolutions TTM interest expense year-on-year change?

Over the past year, EBS TTM interest expense has changed by -$11.40 M (-12.77%)